The Municipal Health Commission's "Four Links" Study Finds Outstanding Problems and Seeks Innovation to Assist the Development Foundation of Shanghai's Biomedical Industry | Clinical | Municipal Health Commission

Release time:Apr 13, 2024 22:00 PM

The biopharmaceutical industry is one of the three leading industries in Shanghai. On the 15th, the Party Group of the Municipal Health Commission conducted extensive research in the early stage, focusing on improving the clinical research system of the city, enhancing the clinical research capabilities of medical and health institutions, and promoting the high-quality development of Shanghai's health industry and biopharmaceutical industry. They carried out "joint learning, joint research, joint rectification, and joint development" learning and exchange. At the meeting, it was reported that the Municipal Health Commission will improve the clinical research system, assist in the development of the biopharmaceutical industry, create a highland for medical development, and seek breakthroughs and innovations as a key topic.

Technology is the primary productive force, talent is the primary resource, and innovation is the primary driving force. In recent years, the Municipal Health Commission has taken the "national municipal hospital" clinical research network as the overall layout, continuously optimizing the clinical research policy environment, focusing on disciplinary talent construction, promoting achievement transformation, leveraging resources from all parties, and promoting high-quality clinical research and clinical trials in medical institutions.

Many hospitals in Shanghai have strong capabilities, abundant clinical resources, and solid scientific research foundations. They focus on the construction of research-oriented hospitals, rely on the National Medical Center, create characteristic key specialties and key discipline groups, strengthen the diagnosis and treatment of critical and difficult diseases, and enhance clinical research and medical technology innovation capabilities.

For example, Shanghai Jiao Tong University and Ruijin Hospital, as the main body of the national major scientific and technological infrastructure for translational medicine, have formed a large-scale equipment scale, integrated core functions, and systematic technical capabilities facility technology system, connecting the complete technology chain of translational medicine research from basic to clinical upstream and downstream. Zhongshan Hospital has applied for over 2400 patents and granted over 1200 patents in the past 10 years, with a total amount exceeding 178 million yuan. The Ninth People's Hospital is characterized by the intersection of medical and industrial fields, with a focus on building an innovative research and development center for medical 3D printing, a precision medicine research institute, and a clinical research center for surgical robots.

Overall, relying on the advantages of high-quality medical resources and talent, Shanghai has achieved remarkable results in medical innovation, clinical research, and transformation with the joint support of various departments, and is at the forefront of the country.


The Municipal Health Commission's "Four Links" Study Finds Outstanding Problems and Seeks Innovation to Assist the Development Foundation of Shanghai's Biomedical Industry | Clinical | Municipal Health Commission

Data shows that in 2021, a total of 8 types of domestically produced innovative drugs were approved in this city, accounting for nearly one-fifth of the total number in the country and ranking among the top in the country. In 2022, there were a total of 3219 Phase I-III clinical trials of drugs under study in this city, a year-on-year increase of 21%. In 2022, a total of 4 varieties of domestically produced innovative drugs were approved in this city, ranking first in the country.

From 2018 to 2022, a total of 51 products in Shanghai entered the national special review process for innovative medical devices, accounting for 18.2% of the national total; 28 innovative medical device registration certificates have been approved, accounting for 17.9% of the national total. Some product technologies have filled the gap in domestic related fields and reached the international advanced level. However, there is still a certain gap in the requirements for building technology innovation centers with global influence.

Managers from multiple medical institutions have had in-depth exchanges on improving the clinical research system in this city and enhancing the clinical research capabilities of medical and health institutions. Wen Daxiang, Secretary of the Party Group and Director of the Municipal Health Commission, stated that technological innovation adheres to "facing the forefront of world science and technology, the main battlefield of the economy, the major needs of the country, and the life and health of the people." The Municipal Health Commission, in conjunction with theme education and relevant departments, plans and collaborates systematically to build the Shanghai medical and health industry into the main battlefield of medical innovation, gradually guiding powerful hospitals to focus on difficult and complex diseases, cutting-edge technology, and technological innovation, and forging the main force of medical innovation.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended